Initial public offering
Shares in Detroit’s newest tech stock soared Thursday, the first day of their trading on the Nasdaq Global Select Market.
OncoMed Pharmaceuticals, a California-based company started at the University of Michigan in 2004 with Taubman Scholar Max Wicha, M.D., as co-founder, raised $82 million in an initial public offering that ended last week.
Esperion Therapeutics Inc. (Nasdaq: ESPR), the Plymouth-based developer of new drugs to lower cholesterol levels in the blood, announced that the underwriters of its recently completed initial public offering have exercised in full their option to purchase an additional 750,000 shares of common stock from Esperion to cover over-allotments.
PLYMOUTH — For the second time, a Michigan company called Esperion Therapeutics is selling stock to the public. Esperion Wednesday announced a $14-a-share price for an initial public offering of 5 million shares. Esperion is […]
Compuware Corp. (Nasdaq:CPWR) plans to sell up to $100 million worth of stock in its Covisint subsidiary.
The Detroit-based software and IT services provider Compuware Corp. (Nasdaq: CPWR) said Friday it submitted a draft registration for a stock sale in its Covisint secure communication portal subsidiary.
General Motors is confirming reports that it will increase the number of common shares to be sold in its Initial Public Offering.
General Motors executives are playing up bright spots in the company’s future as they try to persuade investors to buy stock: a better lineup of cars and trucks, potential for global growth and a new […]
SAIC Motor Corp., China’s largest automaker and a joint-venture partner with General Motors, is preparing to buy about $500 million worth of stock in the Detroit automaker, according to a newspaper website.
General Motors has the potential to make huge pretax profits once global auto sales fully recover, the company’s chief financial officer said Thursday in a video presentation that was posted online.